PubMed 11136720

Referenced in: none

Automatically associated channels: Kv10.1 , Kv11.1 , Kv12.1 , Kv7.1 , Kv7.2 , Kv7.3 , Kv7.4 , SK1 , SK2

Title: An ERG channel inhibitor from the scorpion Buthus eupeus.

Authors: Y V Korolkova, S A Kozlov, A V Lipkin, K A Pluzhnikov, J K Hadley, A K Filippov, D A Brown, K Angelo, D Strøbaek, T Jespersen, S P Olesen, B S Jensen, E V Grishin

Journal, date & volume: J. Biol. Chem., 2001 Mar 30 , 276, 9868-76

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/11136720

Abstract
The isolation of the peptide inhibitor of M-type K(+) current, BeKm-1, from the venom of the Central Asian scorpion Buthus eupeus has been described previously (Fillipov A. K., Kozlov, S. A., Pluzhnikov, K. A., Grishin, E. V., and Brown, D. A. (1996) FEBS Lett. 384, 277-280). Here we report the cloning, expression, and selectivity of BeKm-1. A full-length cDNA of 365 nucleotides encoding the precursor of BeKm-1 was isolated using the rapid amplification of cDNA ends polymerase chain reaction technique from mRNA obtained from scorpion telsons. Sequence analysis of the cDNA revealed that the precursor contains a signal peptide of 21 amino acid residues. The mature toxin consists of 36 amino acid residues. BeKm-1 belongs to the family of scorpion venom potassium channel blockers and represents a new subgroup of these toxins. The recombinant BeKm-1 was produced as a Protein A fusion product in the periplasm of Escherichia coli. After cleavage and high performance liquid chromatography purification, recombinant BeKm-1 displayed the same properties as the native toxin. Three BeKm-1 mutants (R27K, F32K, and R27K/F32K) were generated, purified, and characterized. Recombinant wild-type BeKm-1 and the three mutants partly inhibited the native M-like current in NG108-15 at 100 nm. The effect of the recombinant BeKm-1 on different K(+) channels was also studied. BeKm-1 inhibited hERG1 channels with an IC(50) of 3.3 nm, but had no effect at 100 nm on hEAG, hSK1, rSK2, hIK, hBK, KCNQ1/KCNE1, KCNQ2/KCNQ3, KCNQ4 channels, and minimal effect on rELK1. Thus, BeKm-1 was shown to be a novel specific blocker of hERG1 potassium channels.